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Abstract
Infections with Campylobacter spp. pose a significant health burden worldwide.
The significance of Campylobacter jejuni/Campylobacter coli infection is well
appreciated but the contribution of non-C. jejuni/C. coli spp. to human gastro-
enteritis is largely unknown. In this study, we employed a two-tiered molecular
study on 7194 patient faecal samples received by the Microbiology Department
in Cork University Hospital during 2009. The first step, using EntericBio®
(Serosep), a multiplex PCR system, detected Campylobacter to the genus level.
The second step, utilizing Campylobacter species-specific PCR identified to the
species level. A total of 340 samples were confirmed as Campylobacter genus
positive, 329 of which were identified to species level with 33 samples contain-
ing mixed Campylobacter infections. Campylobacter jejuni, present in 72.4% of
samples, was the most common species detected, however, 27.4% of patient sam-
ples contained non-C. jejuni/C. coli spp.; Campylobacter fetus (2.4%), Campylob-
acter upsaliensis (1.2%), Campylobacter hyointestinalis (1.5%), Campylobacter lari
(0.6%) and an emerging species, Campylobacter ureolyticus (24.4%). We report
a prominent seasonal distribution for campylobacteriosis (Spring), with C. ureo-
lyticus (March) preceeding slightly C. jejuni/C. coli (April/May).
Introduction
Campylobacter-related gastroenteritis is one of the most
common causes of acute bacterial diarrhoeal illness in
both developed and developing countries (Coker et al.,
2002). There is a persistently high incidence of campylo-
bacteriosis in European countries, and the 2007; crude
incidence rate in Ireland was a direct reflection of the
European average of 45.2/100 000 (HSPC, 2007; EFSA,
2009). National surveillance programmes which have been
employed by many industrialized countries have contrib-
uted to improved reporting of Campylobacter infections
(HSPC, 2007). Yet despite the high reported incidence it
is estimated that the true rate of infection may be
between seven and thirty times higher (Crushell et al.,
2004; Moore et al., 2005; Janssen et al., 2008).
Campylobacteriosis is primarily regarded as a zoonosis
and the reservoirs for infection vary depending on the spe-
cies, but encompass a wide range of birds, livestock and
domestic animals (McClurg et al., 2002; Moore et al.,
2005). To date, 26 species are assigned to the Campylo-
bacter genus (Euzeby, 1997), however, only some of these
have been linked with human gastroenteritis (Mandrell
et al., 2005; Moore et al., 2005). Campylobacter jejuni and
Campylobacter coli combined have been reported as
accounting for at least 95% of Campylobacter isolations in
humans with gastroenteritis (Kulkarni et al., 2002; Moore
et al., 2005), when using traditional culture methods for
diagnosis. Advances in molecular diagnostics facilitate
detection of non-C. jejuni/C. coli spp. from clinical sam-
ples (Duffy et al., 2007; Bullman et al., 2011). However, to
date, the true contribution of non-C. jejuni/C. coli species
to human gastroenteritis remains unknown, and the aims
of our study were to determine the proportion of non-C.
jejuni/C. coli Campylobacter in faeces from patients with
acute gastroenteritis, and to analyse the complete collection
of results with regard to seasonality and age distribution.
In this study we employed a two-tiered molecular-
based analysis to examine the distribution of Campylo-
bacter spp. in patients presenting with diarrhoeal illness
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for the calendar year 2009. The first stage of the investiga-
tion was to detect a genus-specific marker for Campylo-
bacter spp., and the second stage sought to determine
identity to species level.
Materials and methods
Patient samples
A total of 7194 faecal samples collected over a 1-year period,
from patients presenting with diarrhoea were screened for
Campylobacter spp. using EntericBio® (Serosep Ltd, Limer-
ick, Ireland). Of these, a total of 349 DNA samples were
included in the study. These samples, stored at 20 °C,
were extracted from anonymized faecal samples that tested
positive for Campylobacter genus using the EntericBio®
system. The samples were received by the Department of
Medical Microbiology at Cork University Hospital, Ireland,
between January 2009 and December 2009.
Control strains
The following control isolates were used in the study:
Campylobacter jejuni ssp. jejuni DSM 4688, Campylobacter
coli DSM 4689, Campylobacter lari ssp. lari DSM 11375,
Campylobacter fetus ssp. fetus DSM 5361, Campylobacter
upsaliensis DSM 5365, Campylobacter hyointestinalis ssp.
hyointestinalis DSM 19053 and Campylobacter ureolyticus
DSM 20703. All control strains were obtained from
DSMZ, Braunschweig, Germany.
PCR template preparation
DNA was extracted from the faecal samples using the
EntericBio® system in accordance with the manufacturer’s
instructions. The extracted DNA samples were either used
immediately in the EntericBio® system or stored at 20 °C
for subsequent use in Campylobacter species-specific and
genus-specific PCR.
PCR assay
The 349 Campylobacter genus positive DNA samples were
investigated using uniplex species-specific PCR assays
for C. jejuni, C. coli, C. lari, C. fetus, C. hyointestinalis,
C. upsaliensis and C. ureolyticus, respectively, according to
the methods used by Bullman et al. (2011).
16S rRNA gene sequencing
A Campylobacter genus-specific PCR targeting the 16S rRNA
gene was conducted on DNA samples that were negative for
species-specific PCR. Samples that produced a PCR
amplicon were subject to 16S rRNA gene sequence analy-
sis (Eurofins MWG Operon, Ebersberg, Germany).
Returned sequences were subjected to BLAST analysis using
the NCBI database and aligned by the CLUSTALW method
in Megalign from the Lasergene suite of programs
(DNAstar). Clinical strains were considered to be identi-
fied when sequence similarities with GenBank entries
exceeded 99% identity over the entire length of the
sequence.
Data collection
On receipt of the samples in the Microbiology Labora-
tory, each patient sample was assigned a unique specimen
record number and the samples were anonymized for the
purposes of this study. Details of the patients’ age and
gender along with sample details and collection informa-
tion were provided on patients who were confirmed
Campylobacter-positive, from which age and gender pro-
files were constructed.
Results
Confirmation of EntericBio® positive
Campylobacter spp. results
Of 7194 patient faecal samples submitted to the Microbiol-
ogy Laboratory from January to December of 2009, a total
of 349 samples were determined to be Campylobacter
genus-positive by the EntericBio® molecular method. Cam-
pylobacter species-specific PCR confirmed the presence of
Campylobacter spp. in 329 (94.3%) of the 349 EntericBio®-
positive samples. Of the 20 samples which were Campylo-
bacter-positive by the EntericBio® but negative for the
species-specific PCR, nine samples were positive for the
Campylobacter genus-specific PCR (targeting the 16S
rRNA gene); however, these samples failed to return
results on sequencing. A further two samples were nega-
tive for the 16S rRNA gene PCR but were recorded as
Campylobacter culture-positive by the clinical Microbiol-
ogy Laboratory; thus, these 11 samples were reported as
non-speciated Campylobacter positives. A total of nine
samples were negative for both Campylobacter species-
specific and genus-specific PCR and were reported as
Campylobacter culture-negative by the clinical Microbiol-
ogy Laboratory; thus, these nine samples were recorded as
false positives. A total of 340 samples of the 349 patient
samples which were positive by the EntericBio® molecular
method were confirmed by alternative molecular methods
(species-specific or genus-specific PCR) and/or routine
culture to be true Campylobacter spp. positives.
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Speciation of Campylobacter-positive samples
Campylobacter spp. were identified in 329 patient samples
by species-specific PCR. There were 373 Campylobacter
detections in all, as 33 samples contained mixed infec-
tions involving a total of 77 Campylobacter detections.
Figure 1 shows the contribution of each species to the
total number of organisms detected. The most common
species, C. jejuni, was detected in 246 (72.4%) of patient
samples and accounted for 66% of the total detections.
Campylobacter ureolyticus was detected in 83 (24.4%)
patient samples, accounting for 22.3% of the total detec-
tions. Campylobacter ureolyticus was the sole Campylo-
bacter species detected in 55 (16.7%) patient samples
(95% confidence interval: 12.8–21.2%). Campylobacter coli
accounted for 6.7%; present in 25 (7.1%) of patient sam-
ples. Collectively C. fetus, C. hyointestinalis, C. upsaliensis
and C. lari amounted to 5% of the total detections.
Age and gender distribution of Campylobacter-
positive patients
Age and gender profiles were constructed (Fig. 2) for the
340 patients confirmed as Campylobacter positive; 52.4%
were men. A bimodal age distribution was noted in both
genders (Fig. 2); 51.8% of all Campylobacter detections
were distributed between two age groups; children under
5 years (31.1%) and adults over 70 years (20.7%). In
male patients, Campylobacter infection was commonest in
those  5 years (37%), whereas in female patients, it
was most frequent in those  70 years (29%) (Fig. 2).
Infection remained at lower levels between late childhood
and the 66–70 age group with the exception of a peak in
male patients aged 41–45 (10.8%).
The age and gender profiles for C. ureolyticus exhibited
a similar bimodal profile to those observed for the com-
bined species, presenting peaks at extremes of age. This
species was more commonly detected in female patients
(62.7%) and more than 50% of detections in female
patients were in the  70 age group (Fig. 2).
Seasonal prevalence of Campylobacter 2009
The hypotheses that the incidence of C. jejuni/C. coli and
of C. ureolyticus is uniformly distributed across the
12 months were conclusively rejected by the chi-square
goodness-of-fit test, showing P-values of 0.000, and 0.003,
respectively).
As shown in Fig. 3, C. jejuni/C. coli infection peaked in
April and May (12.9% and 12.6% of the total, respec-
tively), declined from September onwards and remained
low during the winter months.
An abrupt peak was observed for C. ureolyticus infec-
tions in early spring; 18.1% of the total number of detec-
tions occurred during March. The fewest detections of
C. ureolyticus infections (2.4% of the total) were observed
in December.
Discussion
Campylobacter infections remain a significant public
health issue, not only in terms of morbidity but also
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Fig. 1. The speciation of Campylobacter by PCR: percentage contri-
bution of each species to the total number identified (n = 373).
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Fig. 2. Age and gender profiles of all Campylobacter-positive patients
(n = 340); and age and gender profile of patients (n = 83) who
tested positive for Campylobacter ureolyticus.
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economic cost. In 2006, a total of 175 561 confirmed
cases of campylobacteriosis were reported from 21 Euro-
pean countries (EFSA, 2009), a figure which is thought to
be an underestimate (Moore et al., 2005; Janssen et al.,
2008). Furthermore, the annual cost of Campylobacter
infection in the US is estimated to be at least $8 billion; a
large economic burden (Crushell et al., 2004). Based on
routine culture detection in diagnostic laboratories,
C. jejuni and C. coli have been reported as being the most
prevalent Campylobacter spp. causing human disease and,
as a result, the majority of Campylobacter research has
focused on these two species. With recent advances in
diagnostic methods, there has been an increasing realiza-
tion of the limitations of routine culture for the detection
of non-C. jejuni/C. coli spp. (Lastovica & le Roux, 2000;
Maher et al., 2003; O’Leary et al., 2009; Bullman et al.,
2011). Thus, traditional culture underestimates the true
occurrence of both Campylobacter-related gastroenteritis
and also the emerging campylobacteria that are detectable
by molecular methods in cases of gastroenteritis (Lastovica
& le Roux, 2000; Maher et al., 2003; Bullman et al., 2011).
Herein, we employed a two-tiered molecular detection
method, independent of culture, for the direct detection
of Campylobacter spp. from the faeces of 7194 patients
presenting with diarrhoeal illness.
Of 340 Campylobacter-positive samples, C. jejuni repre-
sented the largest proportion of PCR-positives, present in
72.4% of patients; although it has previously been reported
that this species accounts for at least 80–90% of Campylo-
bacter-related infections (Kovats et al., 2005; Moore et al.,
2005). Campylobacter coli, traditionally ranked as the
second most common Campylobacter species found in
Campylobacter enteritis (Coker et al., 2002; Moore et al.,
2005; Ivanova et al., 2010); was identified in 7.4% of sam-
ples. An emerging species, C. ureolyticus, was detected in
24.4% of cases, and was detected solely (without other bac-
teria or viruses) in the samples of 55 symptomatic patients.
There are a number of reasons why C. ureolyticus fails to
be identified by routine culture: it is incapable of growth
under the microaerobic atmosphere conditions used (5%
O2, 10% CO2 and 85% N2) unless hydrogen is supplied. In
addition, certain strains appear to be sensitive to the anti-
biotic used in the Campylobacter selective agars. Finally,
most clinical laboratories isolate Campylobacter from stools
at incubation temperatures >40 °C; however, C. ureolyticus
fails to grow above 37 °C (Vandamme et al., 2010). To our
knowledge, this is the first report of C. ureolyticus replacing
C. coli as the second most common Campylobacter species
in patients presenting with diarrhoeal illness. Furthermore,
as previously reported (Bullman et al., 2011), given that
only 1.15% of the 7194 samples processed contained this
organism, it is unlikely that C. ureolyticus exists as a com-
mon commensal in the gastrointestinal tract.
In support of the findings of Maher et al. (2003), we
determined that non-C. jejuni/C. coli spp. accounted for
27.4% of the total Campylobacter organisms detected; a
much greater percentage than the previously reported
1–5% (Galanis, 2007; Ivanova et al., 2010). The large pro-
portion of non-C. jejuni/C. coli species in this study is
primarily due to the novel identification of C. ureolyticus,
which as mentioned previously, is not normally isolated
by routine Campylobacter culturing techniques. This find-
ing highlights the advantages of molecular diagnostics
for the detection of such fastidious organisms. Recent
observations by O’Leary et al. (2009), when comparing a
multiplex PCR assay to routine culture indicated that
approximately 30% of samples positive for Campylobacter
by the molecular method failed to grow on culture. Simi-
lar results were reported by Besse`de et al. (2011), who
reported considerably lower sensitivity for culture-based
techniques compared to molecular methods. The hypoth-
esis that the true proportion of Campylobacter detections
due to C. jejuni/C. coli is 95% or more in the current
study is conclusively rejected by the appropriate statistical
test (P-value = 0.000).
The reported incidence of the less commonly grown
campylobacteria varies in different regions of the world
(Moore et al., 2005), and interestingly, we have detected
C. fetus in 2.4% of the Campylobacter-positive samples
(0.11% of the 7194 samples analysed). Campylobacter fetus
has been considered to be a very rare cause of gastroenter-
itis in humans and acts most often as an opportunistic
pathogen in immunocompromised individuals (Umehara
et al., 2009); our findings may suggest the need for further
investigation of this species as a gastrointestinal pathogen.
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Human Campylobacter infection in temperate countries
has been acknowledged as having a seasonal occurrence.
Reports demonstrate a trough during winter months fol-
lowed by a two- to threefold higher peak in late spring or
early summer (Kovats et al., 2005). Our findings reflect
this for the combined Campylobacter spp. as well as for
C. jejuni/C. coli and C. ureolyticus individually. Campylo-
bacter jejuni/C. coli and C. ureolyticus infections peak in
spring. Figure 3 suggests a slightly earlier peak (March) for
C. ureolyticus in comparison to C. jejuni (April and May).
A second epidemiological feature of Campylobacter
infection is that incidence shows associations with patient
age and gender (Crushell et al., 2004). European studies
report (HSPC, 2007, EFSA, 2009) that in developed coun-
tries Campylobacter infection is most common in children
under 5 years; however, a second peak is noted in the
young adult, the 15–24 year age group, which is not
observed in developing countries. In our study, Campylo-
bacter was most frequently detected in the extremes of
age, with more than half of all detections in children
 5 years and adults  70 years. Campylobacter ureolyti-
cus was shown in this study to be more common in
female patients. Previously, Campylobacter infections have
been reported as more common in male patients (Moore
et al., 2005; EFSA, 2009). In addition, the peak which
we report in the elderly (particularly for C. ureolyticus)
accords with a recent study in the UK (Gillespie et al.,
2009), which found that the elderly are the population
most at risk of Campylobacter infection.
In conclusion, the results of our investigation for the
period of January–December inclusive, 2009, in Southern
Ireland, suggest that non-C. jejuni/C. coli spp. contribute
considerably to the proportion of Campylobacter-positive
samples from patients presenting with diarrhoeal illness.
This finding illustrates the power of molecular-based detec-
tion over less sensitive culture techniques (O’Leary et al.,
2009; Bullman et al., 2011). The resulting positive impact
of increased sensitivity of diagnostics on clinical care is
likely to be significant. Although Campylobacter-related
gastroenteritis is usually self-limiting in the immunocom-
petent host, it imposes a high economic burden primarily
due to hospitalization and man hours lost to industry. As
Campylobacter infections are notifiable in Ireland, increased
sensitivity of detection might be expected to heighten infec-
tion control efforts, in particular for organisms such as
C. ureolyticus, whose reservoir is currently unknown.
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